145 related articles for article (PubMed ID: 37594976)
1. Clustering of uveal melanoma: County wide analysis within Ohio.
Clevenger LM; Wrenn JD; Bena J; Sodhi G; Tullio K; Singh AD
PLoS One; 2023; 18(8):e0290284. PubMed ID: 37594976
[TBL] [Abstract][Full Text] [Related]
2. Incidence of uveal melanoma in the United States: 1973-1997.
Singh AD; Topham A
Ophthalmology; 2003 May; 110(5):956-61. PubMed ID: 12750097
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanoma: trends in incidence, treatment, and survival.
Singh AD; Turell ME; Topham AK
Ophthalmology; 2011 Sep; 118(9):1881-5. PubMed ID: 21704381
[TBL] [Abstract][Full Text] [Related]
4. Incidence of uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
[TBL] [Abstract][Full Text] [Related]
5. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).
Aronow ME; Topham AK; Singh AD
Ocul Oncol Pathol; 2018 Apr; 4(3):145-151. PubMed ID: 29765944
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic factors and diagnosis of uveal melanoma in the mid-southern United States.
Shildkrot Y; Thomas F; Al-Hariri A; Fry CL; Haik BG; Wilson MW
Curr Eye Res; 2011 Sep; 36(9):824-30. PubMed ID: 21762015
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015.
Alfaar AS; Saad A; Wiedemann P; Rehak M
Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1723-1731. PubMed ID: 34605956
[TBL] [Abstract][Full Text] [Related]
8. Uveal melanoma incidence trends in Canada: a national comprehensive population-based study.
Ghazawi FM; Darwich R; Le M; Rahme E; Zubarev A; Moreau L; Burnier JV; Sasseville D; Burnier MN; Litvinov IV
Br J Ophthalmol; 2019 Dec; 103(12):1872-1876. PubMed ID: 30819691
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma of the uvea in Iceland 1955-1979.
Gíslason I; Magnússon B; Tulinius H
Acta Ophthalmol (Copenh); 1985 Aug; 63(4):389-94. PubMed ID: 4050358
[TBL] [Abstract][Full Text] [Related]
10. Incidence of uveal melanoma in Sweden from 1960 to 1998.
Bergman L; Seregard S; Nilsson B; Ringborg U; Lundell G; Ragnarsson-Olding B
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2579-83. PubMed ID: 12147588
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma: a study on incidence of additional cancers in the Swedish population.
Bergman L; Nilsson B; Ragnarsson-Olding B; Seregard S
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):72-7. PubMed ID: 16384946
[TBL] [Abstract][Full Text] [Related]
12. Conditional Survival in Uveal Melanoma.
Zabor EC; Radivoyevitch T; Singh AD; Kilic E; de Klein JEMM; Kalirai H; Coupland SE
Ophthalmol Retina; 2021 Jun; 5(6):536-542. PubMed ID: 32979556
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma in England: trends over time and geographical variation.
Keenan TD; Yeates D; Goldacre MJ
Br J Ophthalmol; 2012 Nov; 96(11):1415-9. PubMed ID: 22976582
[TBL] [Abstract][Full Text] [Related]
14. Survival rates with uveal melanoma in the United States: 1973-1997.
Singh AD; Topham A
Ophthalmology; 2003 May; 110(5):962-5. PubMed ID: 12750098
[TBL] [Abstract][Full Text] [Related]
15. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
16. Unique Geospatial Accumulations of Uveal Melanoma.
Orloff M; Brennan M; Sato S; Shields CL; Shields JA; Lally S; Mashayekhi A; Mason J; Materin M; Mastrangelo M; Sato T
Am J Ophthalmol; 2020 Dec; 220():102-109. PubMed ID: 32681908
[TBL] [Abstract][Full Text] [Related]
17. Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted County, Minnesota.
Wilkes SR; Robertson DM; Kurland LT; Campbell RJ
Am J Ophthalmol; 1979 May; 87(5):639-41. PubMed ID: 443334
[TBL] [Abstract][Full Text] [Related]
18. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification.
Stang A; Parkin DM; Ferlay J; Jöckel KH
Int J Cancer; 2005 Mar; 114(1):114-23. PubMed ID: 15523698
[TBL] [Abstract][Full Text] [Related]
19. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma.
Damento GM; Pulido JS; Abbott BA; Hodge DO; Dalvin LA
Mayo Clin Proc; 2019 Jul; 94(7):1287-1295. PubMed ID: 31272570
[TBL] [Abstract][Full Text] [Related]
20. Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study.
Isager P; Østerlind A; Engholm G; Heegaard S; Lindegaard J; Overgaard J; Storm HH
Ophthalmic Epidemiol; 2005 Aug; 12(4):223-32. PubMed ID: 16033743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
